Susquehanna Portfolio Strategies, LLC I Teos Therapeutics, Inc. Transaction History
Susquehanna Portfolio Strategies, LLC
- $4.58 Trillion
- Q2 2025
A detailed history of Susquehanna Portfolio Strategies, LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna Portfolio Strategies, LLC holds 204,708 shares of ITOS stock, worth $2.08 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
204,708Holding current value
$2.08 Million% of portfolio
0.04%Shares
4 transactions
Others Institutions Holding ITOS
# of Institutions
120Shares Held
33.7MCall Options Held
733KPut Options Held
611K-
Eco R1 Capital, LLC San Francisco, CA10.7MShares$108 Million9.18% of portfolio
-
Tang Capital Management LLC San Diego, CA3.83MShares$38.8 Million2.28% of portfolio
-
Black Rock Inc. New York, NY3.73MShares$37.9 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX833KShares$8.45 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA703KShares$7.14 Million0.0% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $361M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...